NRG DT001

Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Sarcoma

Status:

Temporarily Closed

A Phase Ib Trial of Neoadjuvant AMG-232 Concurrent with Preoperative Radiotherapy in Wild-Type P53 Soft Tissue Sarcoma (STS)

NCT#03217266

Effective 09/15/20, NRG DT001, Cohort A (extremity/body wall), is reopened at Dose level 3.

Effective, 04/24/20, NRG DT001, Cohort B, is reactivated to Dose Level 2.